Cashu
Novartis AG Gains FDA Approval for Cosentyx in Pediatric Autoimmune Treatment Options
2 days ago
Stocks
Health Care
nvs
Novartis AG
SWISS EXCHANGE: NVS
-3.86 (-2.49%)
150.99
USD
At close at Mar 18, 16:07 UTC
Latest Novartis AG News
benzinga.com
Novartis Advances Dermatology Portfolio With Cosentyx FDA Approval For Pediatric Patients
2 days ago
benzinga.com
Accenture Acquires AI Leader Faculty, Appoints New CTO
2 days ago
benzinga.com
Why Is Olema Pharmaceuticals Stock Dropping On Monday?
9 days ago
benzinga.com
What's Driving the Market Sentiment Around Novartis AG?
16 days ago
benzinga.com
Second HeLa Lawsuit Resolved As Novartis Reaches Confidential Settlement
18 days ago
benzinga.com
A Look Into Novartis Inc's Price Over Earnings
29 days ago
foxbusiness.com
Trump to unveil TrumpRx website where Americans can purchase prescription drugs
about 1 month ago
cnbc.com
Thursday's big stock stories: What’s likely to move the market in the next trading session
about 1 month ago
cnbc.com
Wednesday's big stock stories: What’s likely to move the market in the next trading session
about 1 month ago
zerohedge.com
Futures Tumble As Plunging Metals And Bitcoin Spark Global Selloff, Margin Calls
about 1 month ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.